Navigation Links
Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Date:9/5/2007

bout Melanoma

Malignant melanoma is the most deadly form of skin cancer. The incidence of this disease is increasing by approximately 4% annually in the U.S. In 2004, the American Cancer Society estimates more than 55,000 cases of malignant melanoma will have been diagnosed. Melanoma is the number one cause of cancer death in women aged 25 to 29. More information about melanoma can be accessed at the Melanoma Research Foundation: http://www.melanoma.org.

About the EADO

The EADO is an international cooperative group dedicated to promote, coordinate and improve clinical and laboratory research activities in skin cancer. Further information about the EADO can be viewed at: http://www.eado.org/.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS (http://www.idispharma.com) on a program whereby both Ganite(R) and Genasense(R) are available on a "named- patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements wit
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
2. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
3. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
4. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
5. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
6. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
7. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
8. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... a member of the Roche Group, announced today a ... for Ventana to ultimately commercialize, a companion diagnostic assay ... The Ventana assay will be used to ... – a chain of natural sugars distributed throughout human ...
(Date:5/27/2015)... 27. Mai 2015 Experten für ... diskutierten im Rahmen einer Spezialpräsentation auf der ... mit der Stretta-Therapie für die ... Infografik - http://photos.prnewswire.com/prnh/20150527/218687-INFO ... MD, von der Case Western Reserve University ...
(Date:5/27/2015)... , May 27, 2015  Easter Seals ... May 31, by launching a national smoking cessation ... caregivers live healthier, tobacco-free lives. Funding for the ... from the CVS Health Foundation. The cessation program highlights ... from Smoking, which take participants ...
Breaking Medicine Technology:Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 2Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 4Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 5DDW-Präsentation untersucht die vielseitige und wirkungsvolle Behandlung von GERD durch Stretta in multiplen Patientengruppen 2DDW-Präsentation untersucht die vielseitige und wirkungsvolle Behandlung von GERD durch Stretta in multiplen Patientengruppen 3DDW-Präsentation untersucht die vielseitige und wirkungsvolle Behandlung von GERD durch Stretta in multiplen Patientengruppen 4CVS Health Foundation, Easter Seals Team Up To Mark World No Tobacco Day With Launch Of New Smoking Cessation Program For Veterans, People With Disabilities 2CVS Health Foundation, Easter Seals Team Up To Mark World No Tobacco Day With Launch Of New Smoking Cessation Program For Veterans, People With Disabilities 3
... Over the past 12 months, the U.S. Food and Drug ... number of approvals in the past decade, surpassed only by ... patients, including: two new treatments for hepatitis C; a drug ... lymphoma in 30 years; and the first new drug for ...
... coupon marketing programs, which lure insured consumers away from ... by $32 billion over the next decade, according to ... Pharmaceutical Care Management Association (PCMA). ... by employers, unions and state governments to reduce costs ...
Cached Medicine Technology:FDA: 35 Innovative New Drugs Approved in Fiscal Year 2011 2FDA: 35 Innovative New Drugs Approved in Fiscal Year 2011 3FDA: 35 Innovative New Drugs Approved in Fiscal Year 2011 4Report: Brand Drug 'Copay Coupons' Raise Health Costs for Employers, Unions, and State Governments by $32 Billion 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 The ... national non-profit and thought leader in research on sex ... Bruises,” an online campaign uniting survivors, advocates, organizations, and ... violence on chronic disease. The campaign features a ... survivors who struggle with chronic disease as a result ...
(Date:5/27/2015)... The Case Management Society of America ... CMSA Lifetime Achievement Award, to Anne Llewellyn RN-BC, MS, ... 25th at the association’s 25th Annual Conference and Expo ... The CMSA Board of Directors awards the Lifetime Achievement ... significant contribution to practice of case management and in ...
(Date:5/27/2015)... CARSON, California (PRWEB) May 27, 2015 ... in quality drinking water filtration products, has announced ... system is one of the first to pass ... Compounds/Incidental Contaminants. The certification is monumental, proving that ... presence of select pharmaceuticals, over-the-counter medications, and chemicals ...
(Date:5/27/2015)... May 27, 2015 One of America's ... upcoming episode of “In America” that takes a look ... is best described as an abnormal heart rhythm. Those ... beats either irregularly or much too quickly. , This ... fibrillation develops in an effort to inform viewers about ...
(Date:5/27/2015)... Cumming, GA (PRWEB) May 27, 2015 ... experts, traveled to six north Georgia cities on May ... as host for local physicians to meet with the ... Over 120 physicians and office staff attended. ... the event is designed to bring together Health Information ...
Breaking Medicine News(10 mins):Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 3Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 2Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 3
... ... IT professionals , ... (PRWEB) May 20, 2010 -- ITSessions today announced a one-day Desktop Virtualization seminar in ... This seminar kicks off a new series of technology and business oriented seminars for ...
... ... empathy is established. A valuing parent/child relationship is required, not just discipline. , ... (PRWEB) May 20, 2010 -- There’s a ... exclusive focus on discipline (to spank or not to spank, etc.) with little to no ...
... the United States over 80,000 people are on the ... waiting for transplants. For most dialysis patients, kidney transplantation ... last decade physicians and surgeons began using organs from ... (DCD)] as an alternative to organs transplanted after donor ...
... effects differ, researchers find , WEDNESDAY, May 19 (HealthDay ... incontinence appear to be equally effective, a new study ... , Known as mid-urethral slings, the techniques are often ... results from activities such as coughing, sneezing or laughing. ...
... It was nearly as effective as face-to-face sessions, researchers say ... depressed, do you need to meet a therapist in person? ... therapy by telephone is almost as effective as face-to-face. ... were newly diagnosed with depression talk to a therapist ...
... Patients with chronic kidney disease who have been diagnosed with ... long-term dialysis treatments or die within a year as those ... found. In the study, appearing in the May 19 ... , researchers monitored for one year 267 patients with chronic ...
Cached Medicine News:Health News:ITSessions Announces Desktop Virtualization Seminar 2Health News:ITSessions Announces Desktop Virtualization Seminar 3Health News:Celebrate Mental Health Month with Your Child; Make Sure a Valuing Relationship is in Place 2Health News:Kidney transplants: Expanding the pool of available organs 2Health News:Female Incontinence Surgeries Look Equally Effective 2Health News:Depressed chronic kidney disease patients more likely to face complications 2Health News:Depressed chronic kidney disease patients more likely to face complications 3
... in two tip styles- the ... staggered eyes, and the angled ... catheter valve options, SAFE-T-VAC and ... with virtually no residual vacuum ...
Catheter Suction 14FR Sterile W/Control Valve...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
... Fluidized Therapy: ,Full-length air fluidization ... provides greater comfort and accelerated healing ... can be defluidized to facilitate patient ... and Reverse Trendelenburg. CPR procedures can ...
Medicine Products: